Vik Chopra Stock Analyst Profile - Wells Fargo Research Coverage - Stocknear

Vik Chopra

Stock Analyst at Wells Fargo

(3.25)
# 2814
Out of 5,470 analysts
51
Total ratings
Success rate
Average return
13 Stocks
Name Action PT Current % Upside Ratings Updated
NPCE NeuroPace
Maintains: Overweight
17 15
9.71 54.48% 3 Aug 13, 2025
GMED Globus Medical
Maintains: Overweight
76 66
59.56 10.81% 10 Aug 8, 2025
ENOV Enovis
Maintains: Overweight
48 41
31.4 30.57% 4 Aug 8, 2025
SOLV Solventum
Maintains: Equal-Weight
75 79
74.65 5.83% 4 Aug 8, 2025
XRAY Dentsply Sirona
Maintains: Equal-Weight
16 15
14.21 5.56% 3 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 19
21.14 -10.12% 3 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
246 199
136.86 45.4% 3 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
205 190
148.79 27.7% 9 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
25 13
15.68 -17.09% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
80 75
67.74 10.72% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
70 57
53.81 5.93% 5 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
26 19
16.34 16.28% 1 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
47 58
39.75 45.21% 2 Feb 10, 2023